Favorable early safety and initial efficacy data from BEST1 program highlighted at premier gathering of global retinal experts with additional ...

Schulman, Ph.D. We have known for some time that changes in the eye may help detect Alzheimer’s disease — a type of dementia affecting about 32 million people globally. Previous research has linked ...

Favorable early safety and initial efficacy data from BEST1 program highlighted at premier gathering of global retinal experts with additional data expected mid-year 2026 - - Reauthorization of FDA's ...

FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...

The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, announced today the appointment of Jason Morris as Board ...

In the news release, Foundation Fighting Blindness Appoints Jason Morris as Board Chair, issued 12-Mar-2026 by Foundation Fighting Blindness over PR Newswire, we are advised by the company that ...

The retina is a thin layer of neural tissue at the back of the eye that detects light and converts it into signals, sent to ...

CRF awards four global grants to advance CHM research toward new clinical trial endpoints and therapeutic approaches—driving progress toward treatments.

Detailed price information for Opus Genetics Inc (IRD-Q) from The Globe and Mail including charting and trades.

Opus Genetics, Inc. (NASDAQ:IRD) is among the 11 Fastest Growing Penny Stocks to Buy Right Now. On March 2, 2026, BTIG raised ...

Learn about the Dental-Skeletal-Retinal Anomaly, a genetic disorder that affects the Cane Corso breed, and understand its impact on the health and well-being of these magnificent dogs. The ...

Ocugen Inc OCGN shares are surging on Wednesday afternoon after Oppenheimer analyst Leland Gershell initiated coverage with an Outperform rating and a $10 price target. Here’s what investors need to ...